Novo Nordisk Cracks Down on Unauthorized Sales of Ozempic and Wegovy.

1 min read
Source: Endpoints News
Novo Nordisk Cracks Down on Unauthorized Sales of Ozempic and Wegovy.
Photo: Endpoints News
TL;DR Summary

Novo Nordisk has filed five initial lawsuits against illegal semaglutide compounders and is preparing to file more in the coming days and weeks. The lawsuits aim to stop the sale of compounded products claiming to include semaglutide and will also tackle false advertising and trademark infringement regarding its semaglutide brands We­govy, Ozem­pic, and Ry­bel­sus.

Share this article

Reading Insights

Total Reads

0

Unique Readers

9

Time Saved

0 min

vs 1 min read

Condensed

47%

10154 words

Want the full story? Read the original article

Read on Endpoints News